Id
|
Protein
|
PTM type
|
Site
|
Species
|
Disease
|
Celline
|
Drug
|
Regulatory
|
Score
|
Ref.
|
acc0351 |
AKT |
phosphorylation |
Ser473 |
human |
Renal Cancer |
786-O |
NVP-BEZ235 |
Negative |
5.0 |
24448243
|
acc0352 |
AKT |
phosphorylation |
Ser473 |
human |
Renal Cancer |
UOK101 |
NVP-BEZ235 |
Negative |
5.0 |
24448243
|
acc0353 |
AKT |
phosphorylation |
Ser473 |
human |
Renal Cancer |
RCC4 |
NVP-BEZ235 |
Negative |
5.0 |
24448243
|
acc0354 |
AKT |
phosphorylation |
Thr308 |
human |
Prostate Cancer |
PC3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0355 |
AKT |
phosphorylation |
Thr308 |
human |
Breast Cancer |
MCF7 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0356 |
p70S6K |
phosphorylation |
Thr389 |
human |
Prostate Cancer |
PC3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0357 |
p70S6K |
phosphorylation |
Thr389 |
human |
Breast Cancer |
MCF7 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0358 |
p70S6K |
phosphorylation |
Thr389 |
human |
Lung Cancer |
A549 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0359 |
p70S6K |
phosphorylation |
Thr389 |
human |
Ovarian Cancer |
OVCAR-3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0360 |
p70S6K |
phosphorylation |
Thr389 |
human |
Glioblastoma |
U87-MG |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0361 |
S6 |
phosphorylation |
Ser240 |
human |
Prostate Cancer |
PC3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0362 |
S6 |
phosphorylation |
Ser240 |
human |
Breast Cancer |
MCF7 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0363 |
S6 |
phosphorylation |
Ser240 |
human |
Lung Cancer |
A549 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0364 |
S6 |
phosphorylation |
Ser240 |
human |
Ovarian Cancer |
OVCAR-3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0365 |
S6 |
phosphorylation |
Ser240 |
human |
Glioblastoma |
U87-MG |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0366 |
AKT |
phosphorylation |
Thr308 |
human |
Lung Cancer |
A549 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0367 |
S6 |
phosphorylation |
Ser244 |
human |
Prostate Cancer |
PC3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0368 |
S6 |
phosphorylation |
Ser244 |
human |
Breast Cancer |
MCF7 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0369 |
S6 |
phosphorylation |
Ser244 |
human |
Lung Cancer |
A549 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0370 |
S6 |
phosphorylation |
Ser244 |
human |
Ovarian Cancer |
OVCAR-3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0371 |
S6 |
phosphorylation |
Ser244 |
human |
Glioblastoma |
U87-MG |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0372 |
AKT |
phosphorylation |
Thr308 |
human |
Ovarian Cancer |
OVCAR-3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0373 |
AKT |
phosphorylation |
Thr308 |
human |
Glioblastoma |
U87-MG |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0374 |
AKT |
phosphorylation |
Ser473 |
human |
Prostate Cancer |
PC3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0375 |
AKT |
phosphorylation |
Ser473 |
human |
Breast Cancer |
MCF7 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0376 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
A549 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0377 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
OVCAR-3 |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0378 |
AKT |
phosphorylation |
Ser473 |
human |
Glioblastoma |
U87-MG |
XL765 (SAR245409) |
Unresolved |
4.0 |
24634413
|
acc0379 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
BxPc-3 |
alpha -Mangostin |
Unresolved |
4.0 |
24812621
|
acc0380 |
AKT |
phosphorylation |
Ser473 |
human |
Pancreas Cancer |
PANC-1 |
alpha -Mangostin |
Unresolved |
4.0 |
24812621
|
acc0381 |
STAT1 |
phosphorylation |
Tyr701 |
human |
Meningioma |
IOMM-Lee |
LB-100 |
Unresolved |
4.0 |
36203966
|
acc0382 |
mTOR |
phosphorylation |
Ser2448 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Radiotherapy |
Negative |
4.5 |
25004403
|
acc0383 |
mTOR |
phosphorylation |
Ser2448 |
mouse |
Hepatocellular Carcinoma |
BNL |
Radiotherapy |
Negative |
4.5 |
25004403
|
acc0384 |
AKT |
phosphorylation |
Ser473 |
human |
Hepatocellular Carcinoma |
HuH-7 |
Radiotherapy |
Negative |
4.5 |
25004403
|
acc0385 |
Akt |
phosphorylation |
Ser473 |
mouse |
Hepatocellular Carcinoma |
BNL |
Radiotherapy |
Negative |
4.5 |
25004403
|
acc0386 |
VASP |
phosphorylation |
Ser239 |
mouse |
Colorectal Cancer |
CT26 |
Baicalein |
Unresolved |
4.0 |
25268843
|
acc0387 |
VASP |
phosphorylation |
Ser157 |
mouse |
Colorectal Cancer |
CT26 |
Baicalein |
Unresolved |
4.0 |
25268843
|
acc0388 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3 |
Bevacizumab |
Negative |
5.0 |
25319392
|
acc0389 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
GOC2 |
Bevacizumab |
Negative |
5.0 |
25319392
|
acc0390 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
GOC-A2 |
Bevacizumab |
Negative |
5.0 |
25319392
|
acc0391 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
OVCAR-3 |
Bevacizumab |
Negative |
5.0 |
25319392
|
acc0392 |
HSP27 |
phosphorylation |
Ser78 |
human |
Colorectal Cancer |
HCT116 |
5-fluorouracil |
Negative |
5.0 |
25364415
|
acc0393 |
HSP27 |
phosphorylation |
Ser78 |
human |
Colorectal Cancer |
HCT15 |
5-fluorouracil |
Negative |
5.0 |
25364415
|
acc0394 |
HSP27 |
phosphorylation |
Ser78 |
human |
Colorectal Cancer |
HT29 |
5-fluorouracil |
Negative |
5.0 |
25364415
|
acc0395 |
ERK1 |
phosphorylation |
Thr202 |
human |
Ovarian Cancer |
TOV112D |
Bortezomib |
Unresolved |
4.0 |
25375375
|
acc0396 |
ERK1 |
phosphorylation |
Thr202 |
human |
Ovarian Cancer |
TOV21G |
Bortezomib |
Unresolved |
4.0 |
25375375
|
acc0397 |
ERK1 |
phosphorylation |
Thr202 |
human |
Endometrial Cancer |
Ishikawa |
Cisplatin |
Positive |
5.0 |
25375375
|
acc0398 |
ERK1 |
phosphorylation |
Thr202 |
human |
Hepatocellular Carcinoma |
HepG2 |
Cisplatin |
Positive |
5.0 |
25375375
|
acc0399 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Ovarian Cancer |
TOV112D |
Cisplatin |
Positive |
5.0 |
25375375
|
acc0400 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Ovarian Cancer |
TOV21G |
Cisplatin |
Positive |
5.0 |
25375375
|